Artificial exosomes can be designed to encapsulate and deliver therapeutic payloads, including drugs, genes, and proteins.

Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs ...

The number of people suffering from osteoarthritis is expected to top 1 billion by 2050. The biggest risk factor for the ...

SOUTH SAN FRANCISCO, CA, USA I April 30, 2025 I Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its second-generation oral norovirus ...